SNY wants to pay 18.5B or so for GENZ. GENZ will make $4.16 at best in 2011 and at 259MM shares that gives 1.08B in gains. So even at that profit, it will take 17 years or so to get back the cost. Is my accounting/view wrong? I know they get the infrastructure etc with the purchase but I'd go after smaller companies with promising drugs than GENZ at that price.
What do I know. I hope SNY's mgt knows what they are doing.